Literature DB >> 12947335

Hypertonic resuscitation of hemorrhagic shock upregulates the anti-inflammatory response by alveolar macrophages.

Kinga A Powers1, James Woo, Rachel G Khadaroo, Giuseppe Papia, Andras Kapus, Ori D Rotstein.   

Abstract

BACKGROUND: Resuscitated hemorrhagic shock predisposes patients to the development of acute respiratory distress syndrome (ARDS). Hypertonic saline (HTS) has been shown to inhibit immune cell activation in response to lipopolysaccharide (LPS) in vitro and to reduce lung damage when used for resuscitation of hemorrhagic shock in vivo. We hypothesize that HTS resuscitation of hemorrhagic shock may exert this anti-inflammatory effect by modulating alveolar macrophage function leading to an altered balance between the proinflammatory and the counter-inflammatory response.
METHODS: A 2-hit rat model of shock resuscitation was used. Alveolar macrophages were harvested by bronchoalveolar lavage (BAL), and tumor necrosis factor (TNF)-alpha and interleukin (IL)-10 were quantified in the cell culture supernatants by enzyme-linked immunosorbent assay (ELISA). Alternatively, 1 hour after resuscitation, animals received endotracheal LPS followed by endotracheal anti-IL-10 neutralizing antibody. Lung injury was determined by measuring BAL neutrophil counts 4 hours after LPS in vivo administration.
RESULTS: Systemic administration of HTS significantly modulates the responsiveness of alveolar macrophages. Specifically, HTS resuscitation inhibited LPS-induced TNF-alpha production while enhancing IL-10 release in response to LPS administered ex vivo and in vivo. Anti-IL-10 antibody in vivo partially reversed the lung protective effect of HTS resuscitation.
CONCLUSIONS: HTS resuscitation exerts an immunomodulatory effect on alveolar macrophages by shifting the balance of pro- and counter-inflammatory cytokine production in favor of an anti-inflammatory response. The in vivo data suggest a causal role for HTS-induced augmented IL-10 as protective. These findings suggest a novel mechanism for the in vivo salutary effect of HTS resuscitation on lung injury after resuscitated hemorrhagic shock.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12947335     DOI: 10.1067/msy.2003.246

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  14 in total

1.  The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double-blinded trial.

Authors:  Sandro B Rizoli; Shawn G Rhind; Pang N Shek; Kenji Inaba; Dennis Filips; Homer Tien; Fred Brenneman; Ori Rotstein
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

2.  The effect of hypoxemic resuscitation from hemorrhagic shock on blood pressure restoration and on oxidative and inflammatory responses.

Authors:  Emmanuel E Douzinas; Olga Livaditi; Ilias Andrianakis; Panagiotis Prigouris; Pantelis Paneris; Vassiliki Villiotou; Alex P Betrosian
Journal:  Intensive Care Med       Date:  2007-12-01       Impact factor: 17.440

3.  Hypertonic saline resuscitation maintains a more balanced profile of T-lymphocyte subpopulations in a rat model of hemorrhagic shock.

Authors:  Yuan-qiang Lu; Xiu-jun Cai; Lin-hui Gu; Han-zhou Mu; Wei-dong Huang
Journal:  J Zhejiang Univ Sci B       Date:  2007-01       Impact factor: 3.066

Review 4.  Intravenous Fluid Therapy in Traumatic Brain Injury and Decompressive Craniectomy.

Authors:  Hernando Raphael Alvis-Miranda; Sandra Milena Castellar-Leones; Luis Rafael Moscote-Salazar
Journal:  Bull Emerg Trauma       Date:  2014-01

5.  Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13.

Authors:  Max Wohlauer; Ernest E Moore; Christopher C Silliman; Miguel Fragoso; Fabia Gamboni; Jeffrey Harr; Frank Accurso; Frank Wright; James Haenel; David Fullerton; Anirban Banerjee
Journal:  Crit Care Med       Date:  2012-09       Impact factor: 7.598

6.  Fluid therapy in neurotrauma: basic and clinical concepts.

Authors:  Hernando Raphael Alvis-Miranda; Andres M Rubiano; Juan C Puyana; Gabriel Alcala-Cerra; Luis Rafael Moscote-Salazar
Journal:  Rev Health Care       Date:  2014

7.  Hypertonic Saline Primes Activation of the p53-p21 Signaling Axis in Human Small Airway Epithelial Cells That Prevents Inflammation Induced by Pro-inflammatory Cytokines.

Authors:  Fabia Gamboni; Cameron Anderson; Sanchayita Mitra; Julie A Reisz; Travis Nemkov; Monika Dzieciatkowska; Kenneth L Jones; Kirk C Hansen; Angelo D'Alessandro; Anirban Banerjee
Journal:  J Proteome Res       Date:  2016-08-29       Impact factor: 4.466

8.  Hypertonic saline attenuates TNF-alpha-induced NF-kappaB activation in pulmonary epithelial cells.

Authors:  Trevor L Nydam; Ernest E Moore; Robert C McIntyre; Franklin L Wright; Fabia Gamboni-Robertson; Phillip C Eckels; Anirban Banerjee
Journal:  Shock       Date:  2009-05       Impact factor: 3.454

Review 9.  Alveolar hypoxia, alveolar macrophages, and systemic inflammation.

Authors:  Jie Chao; John G Wood; Norberto C Gonzalez
Journal:  Respir Res       Date:  2009-06-22

10.  Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients.

Authors:  Shawn G Rhind; Naomi T Crnko; Andrew J Baker; Laurie J Morrison; Pang N Shek; Sandro Scarpelini; Sandro B Rizoli
Journal:  J Neuroinflammation       Date:  2010-01-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.